scholarly journals GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes

2016 ◽  
Vol 52 (3) ◽  
pp. 400-408 ◽  
Author(s):  
Y-B Chen ◽  
T Wang ◽  
M T Hemmer ◽  
C Brady ◽  
D R Couriel ◽  
...  
Keyword(s):  
Risk Factors ◽  
Acute Leukemia ◽  
Cord Blood ◽  
Umbilical Cord ◽  
Umbilical Cord Blood ◽  
Cord Blood Transplantation ◽  
Umbilical Cord Blood Transplantation ◽  
Blood Transplantation

Incidence and risk factors of food allergy after umbilical cord blood transplantation in children

2017 ◽  
Vol 5 (6) ◽  
pp. 1789-1791 ◽  
Author(s):  
Alfonso Hernández-Ojeda ◽  
Nicolás Rojas ◽  
Francisco Barriga ◽  
María Angélica Wietstruck ◽  
Pamela S. Morales ◽  
...  
Keyword(s):  
Risk Factors ◽  
Food Allergy ◽  
Cord Blood ◽  
Umbilical Cord ◽  
Umbilical Cord Blood ◽  
Cord Blood Transplantation ◽  
Umbilical Cord Blood Transplantation ◽  
Blood Transplantation

CMV Infection Alone Does Not Affect The Survival In Patients After Umbilical Cord Blood Transplantation: Can We Put Off The Time Of Preemptive Therapy?

Blood ◽  
2013 ◽  
Vol 122 (21) ◽  
pp. 5458-5458
Author(s):  
Juan Tong ◽  
Zimin Sun ◽  
Huilan Liu ◽  
Kaiyang Ding ◽  
Liangquan Geng ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cord Blood ◽  
Umbilical Cord ◽  
Umbilical Cord Blood ◽  
Cord Blood Transplantation ◽  
Preemptive Therapy ◽  
Umbilical Cord Blood Transplantation ◽  
Cmv Infection ◽  
Blood Transplantation ◽  
Cmv Disease

Abstract Objective Analysis and discuss the time of cytomegalovirus (CMV) preemptive therapy after umbilical cord blood transplantation (UCBT). Analysis the risk factors of CMV infection and the effect on survival of CMV infection after UCBT. Method From April 2000 to March 2013, 176 cases of patients undergo UCBT who were detected plasma CMV-DNA twice a week routinely. Preemptive antiviral therapy was initiated with ganciclovir or foscarnet for positive PCR of 103 DNA copies or more per ml. Results 125 of 176 patients developed CMV infection (71%) at a median of 32d (range 19 to 98) post-transplant and only 4 patients developed CMV disease (2.3%). The 5-year overall (OS) was 59.4% in the patients with CMV infection and 64.9% in patients without CMV infection (P=0.193). The study identified that younger age, high-risk disease, infused little CD34 positive cells, developed III-IV degree acute graft-versus-host disease (GVHD), high-dose methylprednisolone, and treated with basiliximab and other strong immunosuppressive agent as significant risk factors for developing CMV infection. It had nothing to do with the gender of patients, transplantation of UCB units, the conditioning regime, the day of neutrophil recovery and chronic GVHD. Preemptive therapy when the CMV-DNA copies are greater than 103 does not increase the incidence of CMV disease, and the survival has not been impacted. Conclusion Preemptive therapy can be initiated when CMV-DNA copies are greater than 103 which can achieve the same effects in UCBT. Disclosures: No relevant conflicts of interest to declare.

scholarly journals Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia

Blood ◽  
2013 ◽  
Vol 121 (5) ◽  
pp. 752-758 ◽  
Author(s):  
Andromachi Scaradavou ◽  
Claudio G. Brunstein ◽  
Mary Eapen ◽  
Jennifer Le-Rademacher ◽  
Juliet N. Barker ◽  
...  
Keyword(s):  
Acute Leukemia ◽  
Cord Blood ◽  
Umbilical Cord ◽  
Umbilical Cord Blood ◽  
Cord Blood Transplantation ◽  
Umbilical Cord Blood Transplantation ◽  
Blood Transplantation ◽  
Key Points

Key PointsEfficacy of transplanting adequately dosed 1- or 2-cord blood units.

Sign in / Sign up

Export Citation Format

Share Document